The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat

European Journal of Pharmacology

Volumn 307, Issue 2, 1996, Pages 171-181

  McAuley, Moira A ^a   Breu, Volker ^b   Graham, David I ^c   McCulloch, James ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Endothelin; Focal ischemia; Middle cerebral artery occlusion

Indexed keywords

BOSENTAN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; IODOPHENAZONE; RADIOISOTOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; DRUG CEREBROSPINAL FLUID LEVEL; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030603784     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00251-8     Document Type: Article

References (63)

1. Bacic, F., S. Uematsu, R.M. McCarron and M. Spatz, 1992, Secretion of immunoreactive endothelin-1 by capillary and microvascular endothelium of human brain, Neurochem. Res. 17, 699.
2. Barone, F.C., M.Y.T. Globus, W.J. Price, R.F. White, B.L. Storer, G.Z. Feuerstein, R. Busto and E.H. Ohlstein, 1994, Endothelin levels increase in rat focal and global ischaemia, J. Cereb. Blood Flow Metab. 14, 337.
3. Barone, F.C., R.F. White, G.Z. Feuerstein and E.H. Ohlstein, 1995, Endothelin receptor antagonist SB 217242, reduces cerebral focal ischemic brain injury, J. Cardiovasc. Pharmacol. 26, S404.
4. 2+ channel blocker prevents CA1 injury 24 h following selective forebrain ischaemia and reduces infarction following focal ischaemia, J. Cereb. Blood Flow Metab. 14, 903.
5. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid haemorrhage after intracisternal but not intravenous injection, Life Sci. 52, 825.
6. Clozel, M., V. Breu, K. Burri, J.-M. Cassel, W. Fischli, G.A. Gray, G. Hirth, B.-M. Loffler, M. Muller, W. Neidhart and H. Ramuz, 1993, Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist, Nature 365, 759.
7. Clozel, M., V. Breu, G.A. Gray, B. Kalina, B.-M. Loffler, K. Burri, J.-M. Cassel, G. Hirth, M. Muller, W. Neidhart and H. Ramuz, 1994, Pharmacological characterisation of Bosentan, a new potent orally active non-peptide endothelin receptor antagonist, J. Pharmacol. Exp. Ther. 270, 228.
8. Cosentino, F. and Z.S. Katusic, 1994, Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm, Stroke 25, 904.
9. Cosentino, F., E.G. McMahon, J.S. Carter and Z.S. Katusic, 1993, Effect of Endothelin A receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm, J. Cardiovasc. Pharmacol. 22, S332.
10. Couraud, P.-O., O. Durieu-Trautmann, D. Le Nguyen, P. Marin, F. Gilbert and A.D. Strosberg, 1991, Functional endothelin-1 receptors in rat astrocytoma C6, Eur.J. Pharmacol. 206, 191.
11. Duverger, D., I. Voissat, M. Chapelat, P.-E. Chabrier, E. Pirotzky and P. Braquet, 1992, Focal cerebral ischaemia in the rat: measurement of brain tissue endothelin, Circ. Metab. Cerveau 9, 85.
12. Duverger, D., I. Voissat, M. Chapelat, P.-E. Chabrier, E. Pirotzky and P. Braquet, 1993, Effects of phosphoramidon on immunoreactive ET-1 contents in brain and volume infartus of the middle cerebral artery occluded rat, J. Cereb. Blood Flow Metab. 13, S194.
13. Ehrenreich, H., J.H. Kehrl, R.W, Anderson, P. Rieckmann, L. Vitkovic, J.E. Coligan and A. Fauci, 1991, A vasoactive peptide. endothelin 3 is produced by and specifically binds to primary astrocytes, Brain Res. 538, 54.
14. Ehrenreich, H., T. Costa, K.A. Clouse, R.M. Pluta, Y. Ogino, J.E. Coligan and P.R. Burd, 1993, Thrombin is a regulator of astrocytic endothelin-1, Brain Res. 600, 201.
15. Faraci, F.M., 1989, Effects of endothelin and vasopressin on cerebral blood vessels, Am. J. Physiol. 257, H799.
16. Fasano, V.A., R. Urciuoli, P. Bolognese and M. Mostert, 1988, Intraoperative use of laser doppler in the study of cerebral microvascular circulation, Acta Neurochir. 95, 40.
17. Feuerstein, G.Z., J.L. Gu, E.H. Ohlstein, F.C. Barone and T-L. Yue, 1994, Selective endothelin receptor (ETA) antagonist is neuroprotective in gerbil transient forebrain ischaemia, Stroke 25, 264.
18. Foley, P.L., H.H. Caner, N.F. Kassell and K.S. Lee, 1994, Reversal of subarachnoid haemmorhage-induced vasoconstriction with an endothelin receptor antagonist, Neurosurgery 34, 108.
19. Gang-zhi, W., Z. JIn. S. Shu-li, A. Hou-xi, M. Jin-cheng and L. Hui-bo, 1993, Increased plasma endothelin-1 concentration in patients with acute cerebral infarctions and actions of endothelin-1 on pial arterioles of rat, Chin. Med. J. 106, 917.
20. Giad, A., S.J. Gibson, M.T. Herrero, S. Gentleman, S. Lego, M. Yanagisawa, T. Masaki, N.B.N. Ibrahim, Roberts, M.L. Rossi and J.M. Polak, 1991, Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain, Histochemistry 95, 303.
21. Giuffrrida, R., M. Bellomo, G. Polizzi and L. Malatino, 1992, Ischaemia-induced changes in the immunoreactivity for endothelin and other vasoactive peptides in the brain of the mongolian Gerbil, J. Cardiovasc. Pharmacol. 20, S41.
22. Itoh, S., T. Sasaki, K. Ide, K. Ishikawa, M. Nishikibe and M. Yano, 1993. A novel endothelin A receptor antagonist, BQ 485 and its preventive effect on experimental cerebral vasospasm in dogs, Biochem. Biophys. Res. Commun. 195, 969.
23. Jiang, M.H., A. Hoog, K.C. Ma, X.J. Nie, Y. Olsson and W.W. Zhang, 1993, Endothelin-1 like immunoreactivity is expressed in human reactive astrocytes, Neuroreport 4, 935.
24. 125I] endothelin in rat and human brain, Neurosci. Lett. 97, 276.
25. Kaplan, B., S. Brint, J. Tanabe, M. Jacewicz, X.-J. Wang and W. Pulsinelli, 1991, Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischaemia, Stroke 22, 1032.
26. Keskil, I.S., M.K. Baykaner, H. Sencer, O. Ataoglu, E. Ilgit, B. Erdogan, N. Ceviker and Z.S. Ercan, 1994, Alteration of Iloprost of the vasospastic effects of endothelin-1 in rabbit cerebral vessels, Neuroreport 5, 1089.
27. Kitazono, T., D.D. Heistad and F.M. Faraci, 1993, Activation of endothelin B receptors produces dilation of the basilar artery in vivo. Circulation 88, I-170.
28. Kourembanas, S., P.A. Marsden, L.P. McQuillan and D.V. Faller, 1991, Hypoxia induces endothelin gene expression and secretion in cultured human endothelium, J. Clin. Ivest. 88, 1054.
29. Lee, M.E., S.M. De La Monte, M.E. Ng, K.D. Bloch and T. Quartermous, 1990, Expression of the potent vasoconstrictor endothelin in the human central nervous system, J. Clin. Invest. 86, 141.
30. MacCumber, M.C.A. Ross and S. Snyder, 1990, Endothlin in brain, receptors, mitogenesis, and biosynthesis in glial cells, Proc. Natl. Acad. Sci. 87, 2359.
31. Macrae, I.M., M.J. Robinson, M.A. McAuley, J.L. Reid and J. Mc Culloch, 1991, Effects of intracisternal endothelin-1 injection on blood flow to the lower brainstem, Eur. J. Pharmacol. 203, 85.
32. Macrae, I.M., M.J. Robinson, D.I. Graham, J.L. Reid and J. McCulloch, 1993, Endothelin-1 induced reductions in cerebral blood flow: dose dependency, time course and neuropathological consequences, J. Cererb. Blood Flow Metab. 13, 276.
33. Marsault, R., P. Vigne, J.-P. Breittmayer and C. Frelin, 1990, Astrocytes are targets for endothelins and safarotoxins, J. Neurochem. 54, 2142.
34. McAuley, M.A., T.R. Patel, S. Galbraith and J. McCulloch, 1994, Endothelin and its pathophysiological role in the cerebral circulation, in: Proceedings of the Pharmacology of Cerebral Blood Flow, eds. J. Krieglstein and H. Oberpichler-Schwenk (Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart) p. 511.
35. Morita, T., H. Kurihra, K. Maemura, M. Yoshizumi and Y. Yazaki, 1993, Disruption of cytoskeletal structures mediates shear stress-induced endothelin-1 gene expression in cultured porcine aortic endothelial cells, J. Clin. Invest. 92, 1706.
36. A receptor antagonist FR139317, ameliorates cerebral vasospasm in dogs, Life Sci. 52, 1869.
37. Ohlstein, E.H. and B.L. Storer, 1992, Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells, J. Neurosurg. 77, 274.
38. Osborne, K.A, T. Shigeno, A.M. Balarsky, I. Fored, J. McCulloch, G.M. Teasdale and D.I. Graham, 1987, Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia, J. Neurosurg. Psychiat. 50, 402.
39. Patel, J.B. and C. Wilson, 1995, Effect of BQ 123 in the SH rat focal ischaemia model, Fourth International Conference on Endothelin, P173.
40. Patel, T.R., M.A. McAuley and J. McCulloch, 1994, Effects on feline pial arterioles in situ of Bosentan, a non-peptide endothelin receptor antagonist, Eur. J. Pharmacol. 260, 65.
41. Patel, T.R., S. Galbraith, M.A. McAuley and McCulloch, 1996, Increase in endothelin mediated vascular tone following focal cerebral ischaemia in the cat, J. Cereb. Blood Flow Metab. (in press).
42. Robinson, M.J. and J. McCulloch, 1990, Contractile responses to endothelin in feline cortical vessels in situ, J. Cereb. Blood Flow Metab. 10, 285.
43. Roux, S.P.. M. Clozel, U. Sprecher, G. Gray and J.P. Clozel, 1993, Ro 47-0203, A new endothelin receptor antagonist reverses chronic vasospasm in experimental subarachnoid hemorrhage, Circulation 88, 1-170.
44. Roux, S., B.M. Loffler, G.A. Gray, U. Sprecher, M. Clozel and J.P. Clozel, 1995, The role of endothelin in experimental cerebral vasospasm, Neurosurgery 37, 78.
45. 14C] antipyrene, Am. J. Physiol. 234, H59.
46. Salom, J.B., G. Torregrosa, J.F. Miranda, J.A. Alabadi and E. Alborch, 1992, Comparison of the contractile effects of endothelin-1 and safarotoxin S6B in goat isolated cerebral arteries, Br. J. Pharmacol. 106, 95.
47. Schilling, L., G.I. Ferger, H. Ehrenreich and M. Wahl, 1995, Endothelin-3-induced relaxation of isolated rat basilar artery is mediated by an endothelial ET(B)-type endothelin receptor, J. Cereb. Blood Flow Metab. 15, 699.
48. Shepard, A.P. and P.A. Oberg, 1990, Laser Doppler Blood Flowmetry (Kluwer, Boston) p. 1.
49. Shigeno, T., T. Mima, M. Yanagisawa, A. Saito, K. Goto, K., Yamashita, T. Spatz M, D. Stanmirovic, F. Bacic, S. Uematsu and R.M. McCarron, 1994, Vasoconstrictor peptides induce endothelin-1 and prostanoids in human cerebrovascular endothelium, Am. J. Physiol. 266, C654.
50. Stanimirovic, D.B., T. Yamamoto, S. Uematsu and M. Spatz, 1994, Endothelin-1 receptor binding and cellular signal trasduction in cultured human brain endothelial cells, J. Neurochem. 62, 592.
51. Tamura, A., D.I. Graham, J. McCulloch and G.M. Teasdale, 1981, Focal cerbrial ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle ceribral artery occlusion, J. Cereb. Blood Flow Metab. 1, 53.
52. Vigne. P., R. Marsault, J.P. Breittmayer and C. Frelin, 1990, Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells, Biochem. J. 266, 415.
53. Wadhwani, K.C. and S.I. Rapoport, 1990, Blood flow in the central and peripheral nervous system, in: Laser Doppler Blood Flowmetry, eds. A.P. Shephard and P.A. Oberg (Kluwer, Boston) p. 265.
54. Westergren, I., B. Nystrom, A. Hamberger and B.B. Johansson, 1995, Intracerebral dialysis and the blood brain barrier, J. Neurochem. 64. 229.
55. Willette, R.N, C. Sauermelch and R.R. Ruffolo, 1990, Effects of endothelin on cortical microvascular perfusion in rats, Stroke 21, 451.
56. Willette R.N., E.H. Ohlstein, M. Pullen, C.F. Sauermelch, A. Cohen and P. Nambi, 1993, Transient forebrain ischaemia alters acutely endothelin receptor density and immunoreactivity in gerbil brain, Life Sci. 52, 35.
57. Yamashita, M., N.F. Kassell, T. Sasaki, S. Fujiwara, M. Zuccarello and A. Spallone, 1985, Topographical distribution of barrier function in cervico-cephalic arteries of dog, Stroke 16, 875.
58. Yamashita K, Y. Kataoka, M. Niwa, K. Shigematsu, A. Himeno, S. Koizumi, K. Taniyama, 1993, Increased production of endothelins in the hippocampus of stroke-prone spontaneously hypertensive rats following transient forebrain ischaemia: histochemical evidence, Cell. Mol. Neurobiol. 13, 15.
59. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayshi, Y. Mitsui, K. Yazaki, K. Goto and T. Masaki, 1988, A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 332, 411.
60. Yoshimoto, S., Y. Ishizaki, H. Kurihara, T. Sasaki, M. Yoshizumi, M. Yanagisawa, Y. Yazaki, T. Masaki, K. Takakura and S. Murota, 1990, Cerebral microvessel endothelium is producing endothelin, Brain Res. 509, 283.
61. Ziv, I., G. Heminger, R. Djaldetti, A. Achiron, E. Melamed and M. Sokolovsky, 1992, Increased plasma endothelin -1 in acute ischaemic stroke, Stroke 23, 1014.
62. Zuccarello, M., R.M. Rapoport and A. Romano, 1994a, Subarachnoid haemorrhage (SAH)-induced vasospasm may be due to endothelin (ET) release and not decreased endothelium-dependent relaxation (EDR), Stroke 25, 263.
63. Zuccarello, M., A.I. Lewis, R.M. Rapoport, 1994b, Endothelin ETa and ETb receptors in subarachnoid haemorrhage-induced cerebral vasospasm, Eur. J. Pharmacol. 259, R1.